North America Circulating Tumor Cells Market Size & Outlook
North America circulating tumor cells market, 2018-2030 (US$M)
Related Markets
North America circulating tumor cells market highlights
- The North America circulating tumor cells market generated a revenue of USD 4,854.2 million in 2023.
- The market is expected to grow at a CAGR of 12.6% from 2024 to 2030.
- In terms of segment, ctc detection & enrichment methods was the largest revenue generating technology in 2023.
- CTC Analysis is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 4,854.2 million |
| Market revenue in 2030 | USD 11,159.9 million |
| Growth rate | 12.6% (CAGR from 2023 to 2030) |
| Largest segment | Ctc detection & enrichment methods |
| Fastest growing segment | CTC Analysis |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CTC Detection & Enrichment Methods, CTC Direct Detection Methods, CTC Analysis |
| Key market players worldwide | Qiagen NV, Bio-Techne Corp, Praxis Precision Medicines Inc Ordinary Shares, Aviva PLC, Biocept Inc, Neurocrine Biosciences Inc, Greiner Bio-One, Miltenyi Biotec, Icon PLC, Ecolab Inc, Arcus Biosciences Inc, Epic Corp, Screen Holdings Co Ltd, Menarini Group, Vtex Ordinary Shares - Class A, Sysmex Corp, STEMCELL Technologies |
Other key industry trends
- In terms of revenue, North America region accounted for 42.3% of the global circulating tumor cells market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 6,739.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Circulating Tumor Cells Market Scope
Circulating Tumor Cells Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America circulating tumor cells market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to circulating tumor cells market will help companies and investors design strategic landscapes.
Ctc detection & enrichment methods was the largest segment with a revenue share of 66.39% in 2023. Horizon Databook has segmented the North America circulating tumor cells market based on ctc detection & enrichment methods, ctc direct detection methods, ctc analysis covering the revenue growth of each sub-segment from 2018 to 2030.
The high prevalence of cancer in North America is expected to drive the market in this region. Some key drivers are increased awareness of cancer treatment and improved healthcare facilities. Continuous technological developments followed by discoveries of specific antigens and biomarkers are responsible for the estimated growth of the Circulating Tumor Cells (CTC) testing market.
Other key factors that boost market growth include advanced facilities and extensive research. In addition, local presence of key players & research institutions that work on improving CTC testing kits, wellframed reimbursement structure, and advancements in associated technologies, such as personalized medicine, drug discovery, cancer diagnostics, & liquid biopsy, are expected to enhance market growth.
For instance, researchers at the Cleveland Clinic in Ohio developed new liquid biopsy tests that can help diagnose cancer before the onset of symptoms. Such advances are expected to boost North America CTC market.
Reasons to subscribe to North America circulating tumor cells market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America circulating tumor cells market databook
-
Our clientele includes a mix of circulating tumor cells market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America circulating tumor cells market , including forecasts for subscribers. This continent databook contains high-level insights into North America circulating tumor cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America circulating tumor cells market size, by country, 2018-2030 (US$M)
North America Circulating Tumor Cells Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
